Tumour suppressor genes are essential for controlling cell growth and division, acting as the bodyโs "brakes" against uncontrolled proliferation ๐ฆ.
When mutated or inactivated, these safeguards fail, leading to tumour development and cancer.
๐ Key Concepts
- Functions ๐ก๏ธ:
- Regulate cell cycle progression โณ
- Repair DNA damage ๐งช
- Induce apoptosis (programmed cell death) ๐
- Maintain genomic stability ๐ฌ
- Mechanisms of Action โ๏ธ:
- Gatekeepers ๐ โ Directly regulate checkpoints/apoptosis (e.g. p53).
- Caretakers ๐งน โ Preserve genomic integrity via DNA repair (e.g. BRCA1/2).
โญ Key Tumour Suppressor Genes
- p53 ๐งพ โ "Guardian of the genome"
- DNA repair activation after damage.
- Triggers apoptosis if DNA cannot be fixed.
- Mutated in ~50% of all cancers.
- RB (Retinoblastoma) ๐๏ธ
- Controls G1 โ S checkpoint.
- Prevents premature cell division.
- Loss leads to retinoblastoma & other cancers.
- BRCA1 / BRCA2 ๐
- DNA repair by homologous recombination.
- Mutations โ โ risk of breast, ovarian, prostate cancers.
- PTEN โก
- Inhibits PI3K/AKT pathway (cell growth signal).
- Mutations linked to breast, prostate, endometrial cancers.
- APC ๐ฟ
- Regulates Wnt pathway (growth & differentiation).
- Mutations โ Familial Adenomatous Polyposis (FAP), colorectal cancer.
๐งจ Mechanisms of Inactivation
- Mutations โ Point mutations, insertions, deletions โ loss of function.
- Epigenetic Modifications โ DNA methylation/histone changes silence genes.
- Loss of Heterozygosity (LOH) โ Loss of the normal allele when the other is already mutated.
๐ฅ Clinical Relevance
- Diagnosis ๐: Genetic testing for hereditary cancer syndromes (e.g. BRCA1/2).
- Prognosis ๐: p53 mutations often linked to worse outcomes.
- Therapy ๐ฏ: Targeted treatments โ e.g. PARP inhibitors in BRCA-mutated cancers.
๐งพ Cancer Syndromes & Gene Links
- Li-Fraumeni Syndrome ๐งฌ โ p53 mutation โ high risk of sarcomas, breast, brain tumours.
- Retinoblastoma ๐๏ธ โ RB gene mutation โ childhood retinal tumours.
- Familial Adenomatous Polyposis (FAP) ๐ฟ โ APC mutation โ hundreds of colonic polyps, inevitable colorectal cancer if untreated.
- Cowden Syndrome ๐ธ โ PTEN mutation โ benign hamartomas & โ breast, thyroid, endometrial cancers.
๐ Summary
Tumour suppressor genes are the bodyโs natural defence against cancer ๐ฆ.
When inactivated by mutation, methylation, or LOH, cells escape normal controls, leading to malignancy.
Understanding their role is critical for diagnosis, prognosis, and modern targeted therapies.